Prestige Wealth Management Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.92K Hold
34
– – ﹤0.01% 616
2026
Q2
$2.96K Buy
34
+23
+209% +$1.39K ﹤0.01% 698
2026
Q1
$444 Buy
+11
New +$411 ﹤0.01% 976

Other funds holding CORT

Prestige Wealth Management Group's CORT Position: Q3 2026 in Review

Prestige Wealth Management Group held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 34 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Prestige Wealth Management Group first reported a position in CORT in Q1 2026 and has held it in 3 quarters since. 501 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Prestige Wealth Management Group held 34 shares of Corcept Therapeutics worth $3.92K as of Q3 2026.
  • Prestige Wealth Management Group left its Corcept Therapeutics share count unchanged in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q3 2026, its #616 holding.
  • Prestige Wealth Management Group first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 501 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Prestige Wealth Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.